Double-Blind, Triple Dummy, Parallel-Group, Randomized, Six-Month Study To Compare Celecoxib (200 Mg BID) With Diclofenac Sr (75 Mg BID) Plus Omeprazole (20 Mg QD) For Gastrointestinal Events In Subjects With Osteoarthritis And Rheumatoid Arthritis At High-Risk Of Gastrointestinal Adverse Events
Double-Blind, Triple Dummy, Parallel-Group, Randomized, Six-Month Study To Compare Celecoxib (200 Mg BID) With Diclofenac Sr (75 Mg BID) Plus Omeprazole (20 Mg QD) For Gastrointestinal Events In Subjects With Osteoarthritis And Rheumatoid Arthritis At High-Risk Of Gastrointestinal Adverse Events
To determine whether celecoxib is superior to combined therapy with diclofenac and omeprazole in the incidence of clinically significant upper and/or lower gastrointestinal (GI) events in high GI risk subjects with osteoarthritis and/or rheumatoid arthritis.
Inclusion Criteria:
Exclusion Criteria:
Ste Foy, Quebec G1V 3M7, Canada
Bogota, Cundinamarca 0, Colombia
Hyderabad, Andhra Pradesh 500 033, India
Sinapore, 308433, Singapore
Observatory Cape Town, 7925, South Africa
Partida de Bacarot, Alicante 03114, Spain
Kaohsiung Hsien, Taiwan
East Horsley, Leatherhead, Surrey KT24 6QT, United Kingdom
Pound Hill, Crawley, WEST Sussex RH10 7DX, United Kingdom
Vale of Glamorgan, CF62 7EB, United Kingdom